Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luanne M Metz

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Continuum (Minneapolis, Minn.)|June 5, 2019
Clinically Isolated Syndrome and Early Relapsing Multiple SclerosisLuanne M Metz
The New England Journal of Medicine|August 24, 2017
Trial of Minocycline in Clinically Isolated Syndrome of Multiple SclerosisLuanne M Metz, Misha Eliasziw
International Journal of Psychiatry in Medicine|September 25, 2002
Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosisScott B Patten, Luanne M Metz
Lancet (London, England)|March 27, 2018
Effective treatment of progressive MS remains elusiveLuanne M Metz, Wei-Qiao Liu
Neurology|September 11, 2002
Interferon beta1a and depression in secondary progressive MS: data from the SPECTRIMS TrialScott B Patten, Luanne M Metz,
Nature Reviews. Neurology|November 21, 2012
Epigenetic changes in patients with multiple sclerosisMarcus W Koch, Luanne M Metz, Olga Kovalchuk
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 24, 2021
Multiple Sclerosis Clinic Utilization is Associated with Fewer Emergency Department VisitsJodie I Roberts, Christopher Hahn, Luanne M Metz
Trends in Molecular Medicine|November 17, 2012
Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosisMarcus W Koch, Luanne M Metz, Olga Kovalchuk
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 17, 2004
Foreign accent syndrome in a patient with multiple sclerosisJacqueline I Bakker, Suzanne Apeldoorn, Luanne M Metz
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2010
Challenges in screening for depression in multiple sclerosisScott B Patten, Sandy Berzins, Luanne M Metz
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Continuum (Minneapolis, Minn.)|June 5, 2019
Clinically Isolated Syndrome and Early Relapsing Multiple SclerosisLuanne M Metz
The New England Journal of Medicine|August 24, 2017
Trial of Minocycline in Clinically Isolated Syndrome of Multiple SclerosisLuanne M Metz, Misha Eliasziw
International Journal of Psychiatry in Medicine|September 25, 2002
Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosisScott B Patten, Luanne M Metz
Lancet (London, England)|March 27, 2018
Effective treatment of progressive MS remains elusiveLuanne M Metz, Wei-Qiao Liu
Neurology|September 11, 2002
Interferon beta1a and depression in secondary progressive MS: data from the SPECTRIMS TrialScott B Patten, Luanne M Metz,
Nature Reviews. Neurology|November 21, 2012
Epigenetic changes in patients with multiple sclerosisMarcus W Koch, Luanne M Metz, Olga Kovalchuk
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 24, 2021
Multiple Sclerosis Clinic Utilization is Associated with Fewer Emergency Department VisitsJodie I Roberts, Christopher Hahn, Luanne M Metz
Trends in Molecular Medicine|November 17, 2012
Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosisMarcus W Koch, Luanne M Metz, Olga Kovalchuk
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 17, 2004
Foreign accent syndrome in a patient with multiple sclerosisJacqueline I Bakker, Suzanne Apeldoorn, Luanne M Metz
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2010
Challenges in screening for depression in multiple sclerosisScott B Patten, Sandy Berzins, Luanne M Metz
Pageof 10